ATE375338T1 - Verfahren zur aufreinigung von lanzoprazol - Google Patents

Verfahren zur aufreinigung von lanzoprazol

Info

Publication number
ATE375338T1
ATE375338T1 AT03793375T AT03793375T ATE375338T1 AT E375338 T1 ATE375338 T1 AT E375338T1 AT 03793375 T AT03793375 T AT 03793375T AT 03793375 T AT03793375 T AT 03793375T AT E375338 T1 ATE375338 T1 AT E375338T1
Authority
AT
Austria
Prior art keywords
lanzoprazole
purification
lansoprazole
provides
present
Prior art date
Application number
AT03793375T
Other languages
English (en)
Inventor
Claude Singer
Anita Liberman
Irena Veinberg
Nina Finklestein
Tamar Nidam
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Application granted granted Critical
Publication of ATE375338T1 publication Critical patent/ATE375338T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Catalysts (AREA)
AT03793375T 2002-08-21 2003-08-21 Verfahren zur aufreinigung von lanzoprazol ATE375338T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40484502P 2002-08-21 2002-08-21
US41805602P 2002-10-11 2002-10-11

Publications (1)

Publication Number Publication Date
ATE375338T1 true ATE375338T1 (de) 2007-10-15

Family

ID=31949873

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03793375T ATE375338T1 (de) 2002-08-21 2003-08-21 Verfahren zur aufreinigung von lanzoprazol

Country Status (10)

Country Link
US (4) US6909004B2 (de)
EP (1) EP1501824B1 (de)
JP (2) JP2006500380A (de)
AT (1) ATE375338T1 (de)
AU (1) AU2003258335A1 (de)
DE (1) DE60316791T2 (de)
ES (1) ES2294358T3 (de)
IL (1) IL166985A (de)
PT (1) PT1501824E (de)
WO (1) WO2004018454A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2237354T3 (es) * 2002-11-18 2007-11-01 Teva Pharmaceutical Industries Ltd. Lansoprazol estable que contiene mas de 500 ppm, hasta aproximadamente 3.000 ppm de agua y mas de 200 ppm, hasta aproximadamente 5.000 ppm de alcohol.
JP2006516574A (ja) * 2003-02-05 2006-07-06 テバ ファーマシューティカル インダストリーズ リミティド ランソプラゾール安定化方法
AU2006254840B2 (en) * 2005-06-08 2012-08-02 Rigel Pharmaceuticals, Inc. Compositions and methods for inhibition of the JAK pathway
KR100758600B1 (ko) * 2006-01-05 2007-09-13 주식회사 대웅제약 란소프라졸 결정형 ａ의 제조방법
US8129536B2 (en) 2006-09-22 2012-03-06 Orchid Chemicals & Pharmaceuticals Limited Method for the purification of lansoprazole
WO2008087665A2 (en) * 2007-01-18 2008-07-24 Matrix Laboratories Ltd Process for preparation of lansoprazole
WO2010117756A2 (en) * 2009-03-31 2010-10-14 Dr. Reddy's Laboratories Ltd Substituted benzimidazole pharmaceutical formulations
WO2010146428A1 (en) * 2009-06-15 2010-12-23 Orchid Chemicals And Pharmaceuticals Ltd. An improved process for the preparation of rabeprazole
EP2552904A1 (de) * 2010-03-31 2013-02-06 Ranbaxy Laboratories Limited Verfahren zur herstellung von dexlansoprazol
CN103012369B (zh) * 2011-05-23 2014-04-23 中山大学 兰索拉唑n晶型及其制备方法和应用
CN102180866B (zh) * 2011-05-23 2013-03-13 中山大学 兰索拉唑晶型及其制备方法和应用
CA2840309A1 (en) * 2011-06-21 2012-12-27 Ranbaxy Laboratories Limited Process for the preparation of dexlansoprazole
BR112015010067B1 (pt) 2012-11-05 2020-11-10 Monsanto Technology Llc composições herbicidas de baixa volatilidade e concentrado das mesmas
CN109265442A (zh) * 2018-10-12 2019-01-25 河南精康制药有限公司 一种原料药兰索拉唑的精制方法
CN112834627B (zh) * 2019-11-22 2022-05-20 扬子江药业集团有限公司 高效液相色谱法分离测定注射用兰索拉唑有关物质的方法
EP4598528A1 (de) 2022-10-04 2025-08-13 Arsenil Zabirnyk Hemmung der verkalkung der aortenklappe

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
US5433959A (en) 1986-02-13 1995-07-18 Takeda Chemical Industries, Ltd. Stabilized pharmaceutical composition
CA1327010C (en) 1986-02-13 1994-02-15 Tadashi Makino Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production
US5026560A (en) 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
DK171989B1 (da) 1987-08-04 1997-09-08 Takeda Chemical Industries Ltd Fremgangsmåde til fremstilling af 2-(2-pyridylmethylsulfinyl)-benzimidazoler
ES2036948B1 (es) 1991-11-21 1994-09-01 Genesis Para La Investigacion Procedimiento de obtencion de compuestos derivados de piridina.
ES2063705B1 (es) 1993-06-14 1995-07-16 S A L V A T Lab Sa Intermedio para la sintesis de lansoprazol y su procedimiento de obtencion.
TW385306B (en) * 1996-11-14 2000-03-21 Takeda Chemical Industries Ltd Method for producing crystals of benzimidazole derivatives
WO1999002521A1 (en) 1997-07-11 1999-01-21 Eisai Co., Ltd. Processes for the preparation of pyridine derivatives
GB9805558D0 (en) 1998-03-17 1998-05-13 Knoll Ag Chemical process`
SI20019A (sl) * 1998-07-13 2000-02-29 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Izboljšan postopek sinteze 5-metoksi -2-/(4-metoksi-3,5-dimetil-2-piridil)metil/ sulfinil-1H-benzimidazola
US6166213A (en) 1998-08-11 2000-12-26 Merck & Co., Inc. Omeprazole process and compositions thereof
JP3926936B2 (ja) 1998-11-16 2007-06-06 エーザイ・アール・アンド・ディー・マネジメント株式会社 スルホキシド誘導体・アセトン錯体およびその製造法
KR100362947B1 (ko) 1999-09-21 2002-11-30 주식회사 대웅 설폭시드 화합물의 제조방법
ES2163372B1 (es) 2000-03-13 2003-05-01 Esteve Quimica Sa Procedimiento de oxidacion de un grupo tioeter a sulfoxido.
US20040138466A1 (en) * 2001-02-02 2004-07-15 Ilya Avrutov Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1H-benzimidazoles
SK10792003A3 (sk) * 2001-02-02 2004-07-07 Teva Pharmaceutical Industries Ltd. Spôsob výroby substituovaných 2-(2-pyridylmetyl) sulfinyl -1H-benzimidazolov

Also Published As

Publication number Publication date
AU2003258335A1 (en) 2004-03-11
DE60316791T2 (de) 2008-07-24
US20050165060A1 (en) 2005-07-28
EP1501824A1 (de) 2005-02-02
WO2004018454A8 (en) 2005-03-31
US20040192923A1 (en) 2004-09-30
JP2006500380A (ja) 2006-01-05
US20050165061A1 (en) 2005-07-28
US7060837B2 (en) 2006-06-13
ES2294358T3 (es) 2008-04-01
US6909004B2 (en) 2005-06-21
JP2010083897A (ja) 2010-04-15
US7622588B2 (en) 2009-11-24
US20050165059A1 (en) 2005-07-28
DE60316791D1 (de) 2007-11-22
PT1501824E (pt) 2007-11-28
IL166985A (en) 2010-04-15
EP1501824B1 (de) 2007-10-10
WO2004018454A1 (en) 2004-03-04
US7022859B2 (en) 2006-04-04

Similar Documents

Publication Publication Date Title
ATE375338T1 (de) Verfahren zur aufreinigung von lanzoprazol
ATE452870T1 (de) (meth)acrylsaeurekristall und verfahren zur herstellung und aufreinigung von waessriger (meth)acrylsaeure
DE60201480D1 (de) Verfahren zur Herstellung von hochreinem Xylylendiamin
IN2012DN01586A (de)
ATE425121T1 (de) Verfahren zur umwandlung von polysulfanen
DE602005006254D1 (de) Verfahren zur reinigung eines schmelzflüssigen metalls
DE60105113D1 (de) Verfahren zur Herstellung von einem Kristallepoxid
ATE306564T1 (de) Verfahren zur aufreinigung von maltose
DK1789445T3 (da) Fremgangsmåde til fjernelse af fibronektin fra plasmafraktioner
ATE455778T1 (de) Verfahren zur herstellung form i von (s)-(+)- clopidogrelbisulfat
ATE354583T1 (de) Verfahren zur herstellung c-7 substituierter 5- androstene
DE502004008678D1 (de) Verfahren zur Herstellung von gereinigten Elastomeren aus Lösung
ATE358709T1 (de) Verfahren zur herstellung einer lösung enthaltend natriumchlorid und natriumhypochlorid
DE50302888D1 (de) Verfahren zur herstellung reiner thioctsäure
DE60015563D1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
IT1319195B1 (it) Processo per la produzione dell'acido r(+)alfa-lipoico.
ATE390400T1 (de) Verfahren zur herstellung von alpha'-chlorketonen
ATE496038T1 (de) Verfahren zur herstellung von quetiapin
DE60011739D1 (de) Kristallines oder kristallisiertes Säureadditionssalz von Losartan und Verfahren zur Reinigung von Losartan
ATE541838T1 (de) Neue zur synthese von s- und r-omeprazol geeignete verbindungen und ein verfahren zu deren herstellung
AU2003294405A1 (en) Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol
DE60031299D1 (de) Verfahren zur herstellung von (aminomethyl)trifluoromethylcarbinol-derivaten
DE602004014822D1 (de) Neues verfahren zur herstellung von nitrooxyderivaten von paracetamol
DE50008776D1 (de) Verfahren zur gewinnung von bakteriorhodopsin
ATE457304T1 (de) Verfahren zur herstellung von 1,2-dichlorethan freien kristallen von zonisamid und hochreinezonisamidkristalle

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties